PetVivo Holdings, Inc. (PETV)
OTCMKTS: PETV · Delayed Price · USD
0.820
0.00 (0.04%)
Apr 29, 2024, 3:38 PM EDT - Market closed
PetVivo Holdings Revenue
PetVivo Holdings had revenue of $1.05M in the twelve months ending December 31, 2023, with 23.50% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $595.89K with 16.82% year-over-year growth. In the fiscal year ending March 31, 2023, PetVivo Holdings had annual revenue of $917.16K with 693.49% growth.
Revenue (ttm)
$1.05M
Revenue Growth
+23.50%
P/S Ratio
13.15
Revenue / Employee
$41,842
Employees
25
Market Cap
13.75M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 917.16K | 801.58K | 693.49% |
Mar 31, 2022 | 115.59K | 103.01K | 818.95% |
Mar 31, 2021 | 12.58K | 8.99K | 250.56% |
Mar 31, 2020 | 3.59K | -74.35K | -95.40% |
Mar 31, 2019 | 77.94K | 76.43K | 5,061.32% |
Mar 31, 2018 | 1.51K | -5.61K | -78.80% |
Mar 31, 2017 | 7.12K | -67.88K | -90.50% |
Mar 31, 2016 | 75.00K | - | - |
Mar 31, 2015 | 0 | - | - |
Mar 31, 2014 | 0 | - | - |
Mar 31, 2013 | 0 | - | - |
Mar 31, 2012 | 0 | - | - |
Mar 31, 2011 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
PETV News
- 21 days ago - PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA - GlobeNewsWire
- 26 days ago - PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA - GlobeNewsWire
- 6 weeks ago - SmallCapVoice.com Inc. (“SCV”) to Host First Annual Safety Summit featuring Up-and-Coming Public Companies - GlobeNewsWire
- 7 weeks ago - Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer - GlobeNewsWire
- 2 months ago - Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California - GlobeNewsWire
- 2 months ago - PetVivo Reports Third Quarter of Fiscal 2024 Financial Results - GlobeNewsWire
- 2 months ago - PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy - GlobeNewsWire
- 2 months ago - PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024 - GlobeNewsWire